MELODY LEISY: Open Payments
NPI 1821647611 · BRIDGEPORT, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$320 in 18 payments from 5 companies in 2025. Trend: 2023 $186 · 2024 $172 · 2025 $320
Food & beverage: $320
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $142 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $95 |
| ABBVIE INC. | 2 | $49 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: CAPLYTA, ABILIFY MAINTENA, REXULTI, VRAYLAR, SPRAVATO, COBENFY.
Industry payments across NE — which companies pay providers there.
